{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-004329","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2025-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.845059+00:00","generated_at":"2026-05-27T05:03:29.484968+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aspira Women's Health appoints Michael Buhle as CEO, James Crawford as VP of Finance","bullets":["Michael Buhle appointed CEO, adds role to current Chief Commercial Officer duties; effective Jan 28, 2025.","James Crawford appointed VP of Finance, serving as principal financial and accounting officer; joined Aspira in 2021.","Interim CEO Dr. Sandra Milligan remains President of the Company.","No family relationships or material interests with existing directors or officers per Regulation S-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-004329","json":"https://secwatch.observer/filing/0001493152-25-004329.json","markdown":"https://secwatch.observer/filing/0001493152-25-004329.md","text":"https://secwatch.observer/filing/0001493152-25-004329.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/0001493152-25-004329-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T05:03:29.484968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"32e372f36e","claim":"James Crawford was appointed as Vice President of Finance at Aspira Women's Health Inc..","evidence_excerpt":"In addition, on January 28, 2025, the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed James Crawford as the Company’s Vice President of Finance.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/0001493152-25-004329-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Vice President of Finance"}]},{"claim_id":"ea171a900f","claim":"Michael Buhle was appointed as Chief Executive Officer at Aspira Women's Health Inc..","evidence_excerpt":"On January 28, 2025, the Board of Directors of Aspira Women’s Health Inc. (the “Company”) appointed Michael Buhle as the Company’s Chief Executive Officer in addition to his current duties as Chief Commercial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000149315225004329/0001493152-25-004329-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}